Filing Flows › Comparisons › PRGO vs AMRX
Perrigo vs Amneal Pharmaceuticals: PRGO and AMRX compared
Perrigo is the larger company: $989M of revenue in its latest quarter (Q3 2026) against $863M for Amneal Pharmaceuticals (Q3 2026). Amneal Pharmaceuticals is growing faster (+10% against -5% a year earlier). Amneal Pharmaceuticals is more profitable, with an operating margin of 11.1% against 2.3%.
Where the money goes: PRGO and AMRX
Perrigo (PRGO) · Q3 2026
Perrigo, Q3 2026: revenue $989M (-5% year over year), operating margin 2.3%, net loss $27.5M, operating cash flow $96.2M. The chart follows the revenue to costs, profit and cash.
Amneal Pharmaceuticals (AMRX) · Q3 2026
Amneal Pharmaceuticals, Q3 2026: revenue $863M (+10% year over year), operating margin 11.1%, net earnings $12.3M, operating cash flow $98.3M. The chart follows the revenue to costs, profit and cash.
| Perrigo (PRGO) | Amneal Pharmaceuticals (AMRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $989M | $863M |
| Revenue growth, Y/Y | -5% | +10% |
| Gross margin | — | 38.7% |
| Operating margin | 2.3% | 11.1% |
| Net earnings | −$27.5M | $12.3M |
| Net margin | -2.8% | 1.4% |
| Operating cash flow | $96.2M | $98.3M |
| Free cash flow | $78.7M | $66.5M |
| Market value | $2.2B | $6.6B |
| P/E | — | 30.7× |
| Analysts’ mean target | $18.00 | $23.86 |
Questions
Which is bigger, Perrigo or Amneal Pharmaceuticals?
Perrigo is the larger company: $989M of revenue in its latest quarter (Q3 2026) against $863M for Amneal Pharmaceuticals (Q3 2026).
Is Perrigo or Amneal Pharmaceuticals growing faster?
Amneal Pharmaceuticals is growing faster (+10% against -5% a year earlier).
Which is more profitable, Perrigo or Amneal Pharmaceuticals?
Amneal Pharmaceuticals is more profitable, with an operating margin of 11.1% against 2.3%.
More: Perrigo earnings · how Perrigo makes money · Amneal Pharmaceuticals earnings · how Amneal Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 8-K filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.